Data / Form D filings / Goldenrod Therapeutics, Inc.
Goldenrod Therapeutics, Inc.: Form D filing
Goldenrod Therapeutics, Inc., a biotechnology company in Houston, TX, filed a Form D with the SEC in 2026. The latest, on June 3, 2026, reports $3.2 million sold of a $6.5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3900 ESSEX LANE, SUITE 575, Houston, TX, 77027
- Phone
- (713) 966-5844
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Texas
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2127885
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | New notice | $6,510,000 | $3,245,355 | $3,264,645 | 2 | May 26, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Leo Linbeck III | Director | |
| Atul Varadhachary | Executive Officer, Director | |
| Thomas Brenninkmeijer | Director | |
| Dev Chatterjee | Executive Officer | |
| Leo Linbeck IV | Executive Officer | |
| Mark Worscheh | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Goldenrod Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.